A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma.
Current opinion in hematology.
Times cited: 6
Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine.
American Journal of Clinical Oncology: Cancer Clinical Trials.
Times cited: 42